1. Home
  2. STEC vs ENLV Comparison

STEC vs ENLV Comparison

Compare STEC & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STEC
  • ENLV
  • Stock Information
  • Founded
  • STEC 2006
  • ENLV 2005
  • Country
  • STEC China
  • ENLV Israel
  • Employees
  • STEC N/A
  • ENLV N/A
  • Industry
  • STEC
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • STEC
  • ENLV Health Care
  • Exchange
  • STEC NYSE
  • ENLV Nasdaq
  • Market Cap
  • STEC 19.0M
  • ENLV 20.7M
  • IPO Year
  • STEC 2021
  • ENLV 1995
  • Fundamental
  • Price
  • STEC $1.31
  • ENLV $0.95
  • Analyst Decision
  • STEC
  • ENLV Strong Buy
  • Analyst Count
  • STEC 0
  • ENLV 2
  • Target Price
  • STEC N/A
  • ENLV $10.00
  • AVG Volume (30 Days)
  • STEC 42.6K
  • ENLV 141.4K
  • Earning Date
  • STEC 04-15-2025
  • ENLV 04-15-2025
  • Dividend Yield
  • STEC N/A
  • ENLV N/A
  • EPS Growth
  • STEC N/A
  • ENLV N/A
  • EPS
  • STEC N/A
  • ENLV N/A
  • Revenue
  • STEC $260,474,693.00
  • ENLV N/A
  • Revenue This Year
  • STEC $9.76
  • ENLV N/A
  • Revenue Next Year
  • STEC $15.85
  • ENLV N/A
  • P/E Ratio
  • STEC N/A
  • ENLV N/A
  • Revenue Growth
  • STEC N/A
  • ENLV N/A
  • 52 Week Low
  • STEC $0.20
  • ENLV $0.81
  • 52 Week High
  • STEC $3.25
  • ENLV $4.43
  • Technical
  • Relative Strength Index (RSI)
  • STEC 48.81
  • ENLV 40.24
  • Support Level
  • STEC $1.21
  • ENLV $0.92
  • Resistance Level
  • STEC $1.54
  • ENLV $1.13
  • Average True Range (ATR)
  • STEC 0.12
  • ENLV 0.09
  • MACD
  • STEC -0.04
  • ENLV -0.02
  • Stochastic Oscillator
  • STEC 30.30
  • ENLV 8.25

About STEC SANTECH HOLDINGS LIMITED

Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: